Automated detection of medication administration errors in neonatal intensive care  by Li, Qi et al.
Journal of Biomedical Informatics 57 (2015) 124–133Contents lists available at ScienceDirect
Journal of Biomedical Informatics
journal homepage: www.elsevier .com/locate /y jb inAutomated detection of medication administration errors in neonatal
intensive carehttp://dx.doi.org/10.1016/j.jbi.2015.07.012
1532-0464/ 2015 Elsevier Inc. All rights reserved.
Abbreviations: CCHMC, Cincinnati Children’s Hospital Medical Center; CPOE,
computerized provider order entry; EHR, electronic health record; IVF, intravenous
ﬂuid; eMAR, electronic medication administration record; NICU, neonatal intensive
care unit; NLP, natural language processing; PPV, positive predictive value; PN,
parenteral nutrition; MRN, medical record number; MAE, medication administra-
tion error.
⇑ Corresponding author at: Division of Neonatology, Cincinnati Children’s
Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, United States.
Tel.: +1 (513) 803 0022 (O); fax: +1 (513) 803 0968.
E-mail address: Kristin.Melton@cchmc.org (K. Melton).Qi Li b, Eric S. Kirkendall b,c,d, Eric S. Hall a,b, Yizhao Ni b, Todd Lingren b, Megan Kaiser b, Nataline Lingren b,
Haijun Zhai b, Imre Solti b,d, Kristin Melton a,⇑
aDivision of Neonatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States
bDivision of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States
cDivision of Hospital Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States
d James M. Anderson Center for Health Systems Excellence, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States
a r t i c l e i n f o a b s t r a c tArticle history:
Received 8 January 2015
Revised 20 April 2015
Accepted 12 July 2015
Available online 17 July 2015
Keywords:
Medication error detection
Medication administration errors
Medication administration
Electronic health record
Computerized algorithms
Patient safetyObjective: To improve neonatal patient safety through automated detection of medication administration
errors (MAEs) in high alert medications including narcotics, vasoactive medication, intravenous ﬂuids,
parenteral nutrition, and insulin using the electronic health record (EHR); to evaluate rates of MAEs in
neonatal care; and to compare the performance of computerized algorithms to traditional incident
reporting for error detection.
Methods: We developed novel computerized algorithms to identify MAEs within the EHR of all neonatal
patients treated in a level four neonatal intensive care unit (NICU) in 2011 and 2012. We evaluated the
rates and types of MAEs identiﬁed by the automated algorithms and compared their performance to inci-
dent reporting. Performance was evaluated by physician chart review.
Results: In the combined 2011 and 2012 NICU data sets, the automated algorithms identiﬁed MAEs at the
following rates: fentanyl, 0.4% (4 errors/1005 fentanyl administration records); morphine, 0.3%
(11/4009); dobutamine, 0 (0/10); and milrinone, 0.3% (5/1925). We found higher MAE rates for other
vasoactive medications including: dopamine, 11.6% (5/43); epinephrine, 10.0% (289/2890); and vaso-
pressin, 12.8% (54/421). Fluid administration error rates were similar: intravenous ﬂuids, 3.2%
(273/8567); parenteral nutrition, 3.2% (649/20124); and lipid administration, 1.3% (203/15227). We also
found 13 insulin administration errors with a resulting rate of 2.9% (13/456). MAE rates were higher for
medications that were adjusted frequently and ﬂuids administered concurrently. The algorithms identi-
ﬁed many previously unidentiﬁed errors, demonstrating signiﬁcantly better sensitivity (82% vs. 5%) and
precision (70% vs. 50%) than incident reporting for error recognition.
Conclusions: Automated detection of medication administration errors through the EHR is feasible and
performs better than currently used incident reporting systems. Automated algorithms may be useful
for real-time error identiﬁcation and mitigation.
 2015 Elsevier Inc. All rights reserved.1. Introduction
The Institute of Medicine report To Err is Human raised public
and practitioner awareness about the frequency of errors in medi-
cal practice, while the 2006 report Preventing Medication Errors
focused attention on the frequency and consequences of medica-
tion errors [1,2]. Error identiﬁcation remains a signiﬁcant issue
because traditionally used systems like incident reporting and trig-
ger tools are known to detect only a fraction of medication errors
[3–7]. Although trigger tools have demonstrated improved ability
to identify errors compared to incident reporting, application of
trigger tools remains resource-intensive, requiring manual chart
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Furthermore, retrospective identiﬁcation of errors through manual
review precludes timely mitigation of harm [10].
Medication errors are the most common medical errors experi-
enced by patients [11,12]. Studies have shown that medication
errors with the potential to cause harm occur three times more fre-
quently in the pediatric inpatient population than the adult popu-
lation [13]. Neonates are even more susceptible to medication
errors due to drug dosing that is inﬂuenced by weight, gestational
age and postnatal age [14–16]. The broad range of patient weights
in the neonatal population (500 g to ﬁve kg) ampliﬁes the severity
of dosing errors [14,17–21].
Because incident reporting and trigger tools are suboptimal for
identifying medication errors, new methods for error identiﬁcation
must be developed. The electronic health record (EHR) with com-
puterized provider order entry (CPOE) and an electronic medica-
tion administration record (eMAR) offer a means to evaluate all
medication orders and administrations efﬁciently and rapidly.
The EHR can be used to evaluate larger cohorts with less resource
utilization than that required by trigger tool analyses or manual
chart review, making it a rich resource for medication error identi-
ﬁcation [22–24]. The EHR also has potential for enabling real-time
identiﬁcation of certain error types.
The medication cycle consists of ﬁve phases: (1) Ordering, (2)
Transcribing, (3) Dispensing, (4) Administering and (5)
Monitoring. Multiple studies have shown that the majority of
errors occur during the ordering and administering phases of the
medication cycle [25–27]. A signiﬁcant effort has been made to
reduce errors during the ordering phase through the use of com-
puterized provider order entry and clinical decision support with
success [28–33]. We chose to focus on developing a tool for iden-
tifying and ultimately mitigating errors that occur in the otherTable 1
Description and descriptive statistics of NICU EHR data evaluated.
Data description
Medication orders Medications ordered by
include:
– medical record num
– medication order I
– medication name
– ordered dose stren
– ordered dose frequ
– medication start da
– medication end da
– dosing weight
– time stamp
Medication order audit Audit data describes ch
order made by the phy
dose, or frequency and
change
Electronic medication administration record Electronic medication a
(eMAR) includes:
– administered dose
– strength
– route
– time of administrat
Laboratory results Laboratory result provi
units for each laborato
the specimen was obta
Nursing communication orders Free-text order for phy
communication deﬁnes
parameters for ﬂuids a
Enteral feeding orders Free-text order deﬁnes
during rate weaningharmful phase of the medication cycle, the medication administra-
tion phase.
The overall goal of our work is to automate error detection in
the neonatal intensive care unit (NICU) and reduce harm using
the EHR. The speciﬁc aims of this study are to (1) develop comput-
erized algorithms for identiﬁcation of medication administration
errors (MAEs) in the EHR, (2) test the capacity of the computerized
algorithms to detect MAEs for speciﬁc high-alert medications in a
large NICU setting, and (3) compare the frequency and type of
MAEs identiﬁed by the algorithms to those reported through inci-
dent reporting and trigger tool methods during the same time
period.2. Materials and methods
2.1. Setting
Cincinnati Children’s Hospital Medical Center (CCHMC) houses
a level four NICU which provides the highest level of neonatal
intensive care to complex and critically ill newborns requiring
extracorporeal mechanical oxygenation (ECMO), surgical, and sub-
specialty care. The NICU has 59 registered beds and had 738 and
734 admissions in years 2011 and 2012 respectively. Most patients
are admitted as transfers from other facilities and have an average
gestational age of 35 weeks and an average length of stay of
26.6 days.
NICU safety interventions in place at the beginning of the study
included the use of computerized provider order entry with clinical
decision support, a barcode medication administration system,
smart infusion pump technology which includes a customized
neonatal library of 158 medications, daily rounding andNumber of NICU entries/objects
evaluated
2011 2012
physicians. Extracted data 38,282 37,439
ber
D
gth
ency
te
te
anges to the medication
sicians, including changes in
the time stamp of the
90,874 112,898
dministration record 180,595 210,231
ion for ordered medications
des numerical values and
ry test, and reports the time
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333,014 543,092
sician to nurse
weaning rates and
nd medications
18,694 17,762
the rate of lipids and PN 15,466 17,697
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guidelines for high-risk medications.
2.2. Data sources
2.2.1. Electronic health record data
We collected data from the EHR and voluntary incident report-
ing system for all CCHMC NICU patients treated in 2011 and 2012,
representing a total of 16,388 patient days in 2011 and 16,685
patient days in 2012. This study protocol was approved by the
CCHMC Institutional Review Board (IRB).
An EHR (Epic Systems, Verona, WI), introduced at CCHMC in
March 2007, captures clinical data including medication orders
entered via a CPOE module. All study data were extracted from
the EHR data warehouse including information pertaining to
medication order history, medication audit trail data, electronic
medication administration record (eMAR) data, laboratory results,
enteral feeding orders and nursing communication orders. The
number of analyzed entries is described in Table 1.
2.2.2. Voluntary incident reporting data set
Incident reports are collected through voluntary reporting using
Risk MonitorPro (RL Solutions, Cambridge, MA) [34]. Structured
reports can be submitted by any employee, either anonymously
or with identiﬁcation, using an intranet link provided on all hospi-
tal computers or directly through an EHR user interface. Required
report ﬁelds include the incident type, incident date, patient name
and medical record number, clinical unit, contributing factors,
immediate actions taken, harm assessment, and a brief description
of the event. Training encourages participants to report a brief
description of all potential events, including errors that reach the
patient and cause harm, those that reach the patient but do not
cause harm, and near misses that do not reach the patient. We ana-
lyzed NICU-speciﬁc reports submitted through the voluntary
reporting system in 2011 and 2012.
2.2.3. Trigger tool data set
CCHMC utilizes the Children’s Hospital Association pediatric
trigger tool for measuring adverse drug events. Each month, 20Fig. 1. General architecture ofrandom charts from patients admitted to the institution for greater
than 48 h are evaluated using manual chart review. The identiﬁca-
tion of any trigger for 15 speciﬁc events within a reviewed chart
spurs a more extensive chart review for errors (Appendix A). We
analyzed NICU-speciﬁc trigger tool evaluations performed in
2011 and 2012.
2.3. Deﬁnitions
Medication administration: A single eMAR record, indicating a
medication dose was administered.
Medication administration error (MAE): Dose or rate recorded
in the eMAR does not match the medication dose or rate ordered
in the medication order or medication order audit.
MAE rate: The total number of erroneous eMAR records/total
number of eMAR records for a given medication. Given that we
analyzed dosing errors only, and did not assess for timing or route
errors, only one MAE could be identiﬁed per eMAR record.
2.4. Algorithm development
Algorithm rules were speciﬁed by the neonatologist based on
standard care practices, reviewed by the physicians on the research
team, and implemented by the programmer. We developed the
algorithms in the following research workﬂow:
(1) Following initial team discussion, the neonatologist pro-
vided algorithm speciﬁcations in a written document. The
algorithms compared the most recent medication orders,
order audits, enteral feeding orders and nursing communica-
tion orders with eMAR entries and generated an error pre-
diction output (Fig. 1). The unit of analysis was a single
eMAR record. The output consisted of matching ordered
medication doses with those recorded on the eMAR in
chronologic order with subsequent identiﬁcation of correct
matches or errors. Ordered medication doses were extracted
from both structured data that resided in ﬁxed data ﬁelds
and unstructured data found in free-text order ﬁelds. Data
was extracted from the unstructured free-text commentsMAE detection algorithms.
Fig. 2. Narcotic/vasoactive MAE detection algorithm.
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(NLP). The algorithms were designed to detect a discrepancy
of 0.1 difference between the ordered and administered
doses, and to detect MAEs only, with the assumption of cor-
rect orders. Given that continuous medications may be
weaned based on verbal orders in the NICU, we allowed a
30-min time discrepancy between eMAR entries and orders
for all medications. This allowed providers time to enter the
verbal order electronically into CPOE, which is enforced by
policy at CCHMC. Due to the risk of miscommunication
and error with verbal orders, orders placed outside of
30 min were considered errors.
(2) Based on the speciﬁcations, the programmer implemented
the algorithm.
(3) Patient data from 2011 was used to guide algorithm devel-
opment. Prototype algorithms were tested and manually
evaluated for compliance with physician speciﬁcations.
This process was not only an engineering quality assurance
step but aided in discovery of additional error scenarios
missing from the initial algorithm. If new errors were iden-
tiﬁed, the algorithm was reﬁned. The iterative development
process repeated until adequate sensitivity was achieved.
(4) The ﬁnal algorithmwas executed on the EHR data from 2011
and 2012.
In the following, we provide details of the developed
algorithms.
2.4.1. Narcotics
To assess narcotic MAEs, the algorithm compared the ordered
dose with the administered dose for continuous morphine and fen-
tanyl. The algorithm aligned the ordered and administered dose
according to the action timestamp, as shown in Fig. 2. If the
ordered dose was not equal to the administered dose, an error
was identiﬁed.
2.4.2. Vasoactive medications
To assess for vasoactive MAEs, the algorithm evaluated for
agreement between medication orders and administrations for
dobutamine, dopamine, epinephrine, milrinone and vasopressin.
In the CCHMC NICU, vasoactive medications can be weaned by
nurses based on physician orders that include weaning dose and
blood pressure parameters. For example, order comments may
state ‘‘Please wean epinephrine by 0.01 lg/kg/min every hour forblood pressure means >45 mmHg’’. We evaluated orders to identify
weaning doses but did not assess for time consistency or blood
pressure correlation (Fig. 2).
2.4.3. Intravenous ﬂuids (IVF), parenteral nutrition (PN) and lipids
To assess for IVF, PN or lipid MAEs, the algorithm compared the
ordered dose with the administered dose. The ordered dose was
found in structured data ﬁelds like PN/lipid orders and order audit
data, and in unstructured free-text ﬁelds including order com-
ments (in medication orders), order administration instructions
(in medication orders), enteral feeding order comments and nurs-
ing communication orders. The PN/lipid MAE detection algorithm
is shown in Fig. 3, and IVF MAE detection algorithm is shown in
Fig. 4. The algorithm aligned the ordered and administered dose
according to the action timestamp. If the ordered dose was not
equal to the administered dose, an error was identiﬁed. The case
analysis for these MAE types is detailed in Appendix B.
We characterized the rate descriptions and rate changes by four
methods: (1) absolute rate, where absolute ﬂuid rates are deﬁned
(e.g. Decrease IVF to 9.2 ml/h), (2) rate change, where a change
value is deﬁned (e.g. Decrease PN by 1 ml/h), (3) parenteral ﬂuid
and enteral feed 1:1 changes, where orders specify rates of enteral
feeding increase and PN decrease (e.g. Decrease PN 1:1 when
advancing feeds by 1 ml/h), and (4) total combined rate of par-
enteral ﬂuids and enteral feeds, where orders specify a combined
rate (e.g. PN + feeds = 28 ml/h). The patterns used for characteriza-
tion were identiﬁed by NLP-based regular expression and the iden-
tiﬁcation performance for each pattern is listed in Appendix C. In
order to evaluate the ability of the algorithm to extract study rele-
vant information from the unstructured data comments of enteral
feeding orders or nursing communication orders, two trained chart
reviewers double annotated 1100 randomly selected comments
(100 for the pilot study and 1000 for the evaluation) using a
plug-in, Knowtator, for the annotation task with a graphic user
interface [35]. The details of the NLP techniques used for informa-
tion extraction, including gold standard development, annotator
training and annotations have been previously described [36–40].
We report the positive predictive value (PPV) and sensitivity of
the NLP algorithms for identifying unstructured entries in
Appendix C.
2.4.4. Insulin
To assess for insulin administration errors, the algorithm evalu-
ated for agreement between insulin orders and administrations. To
Fig. 3. PN/lipid administration error detection algorithm.
Fig. 4. IVF administration error detection algorithm.
Table 2
Insulin administration clinical guideline.
Initiation: Requires two consecutive blood glucose measurements > 180 mg/dL measured one hour apart while receiving a
delivered glucose infusion rate of < 5 mg/kg/min
Glucose level parameters Insulin titration
Initial dose
Glucose > 180 mg/dL and < 250 mg/dL Start insulin at 0.01 units/kg/h
Glucose > 250 mg/dL and < 300 mg/dL Start insulin at 0.02 units/kg/h
Glucose > 300 mg/dL Start insulin at 0.03 units/kg/h
Discontinuation
If glucose level < 100 mg/dL Discontinue insulin
If glucose level is decreasing > 50 mg/dL/h and blood glucose is < 200 mg/dL Discontinue insulin
128 Q. Li et al. / Journal of Biomedical Informatics 57 (2015) 124–133standardize insulin treatment, a clinical guideline for insulin
administration in the NICU was introduced at CCHMC in 2010.
We also assessed for adherence to guideline recommendations.
To assess for appropriate initiation of insulin, the algorithmevaluated whether infants met the guideline criteria of two consec-
utive blood glucose measurements >180 mg/dL measured one hour
apart while receiving a delivered glucose infusion rate of
<5 mg/kg/min. The algorithm also evaluated whether insulin was
Q. Li et al. / Journal of Biomedical Informatics 57 (2015) 124–133 129initiated at the guideline-speciﬁed dose and whether guideline
parameters for discontinuation were followed (Table 2). The algo-
rithm is presented in Appendix D.2.5. Error validation by chart review
We evaluated the algorithms in the following research
workﬂow:
(1) To generate a gold standard or reference standard for perfor-
mance evaluation of the algorithms, two independent
reviewers, including one neonatologist, performed manual
review of 1000 randomly selected orders and their associ-
ated eMAR entries from the 2012 data set for each studied
medication. This included review of all administrations,
not just those with errors. The 2012 data set was used as
an unbiased data set that had not been used previously for
algorithm development. If less than 1000 orders existed for
a given medication, all orders and eMAR entries were
reviewed. The sample size of 1000 medication orders was
chosen because it provides the power to detect a sensitivity
of 99%. The 2-sided 95% conﬁdence interval for this sensitiv-
ity was expected to be 97.9–100%. Reviewers indicated an
error was present when eMAR administration records dif-
fered from ordered medication doses. Consistent with algo-
rithm speciﬁcations, reviewers evaluated administration
errors based on an assumption of correct order entry.
Reviewers were blinded to the algorithm error assessment
at the time of review.
(2) Incident reports were reviewed for the studied medications.
Physician experts validated the incident reporting data at
the time of analysis.
(3) Algorithm output and errors identiﬁed by incident reporting
were then compared to the reference standard to determine
performance of each method. We report the sensitivity,
speciﬁcity, and PPV of the MAE algorithm performance for
each medication. We report administration error rates for
both 2011 and 2012 according to the ﬁnalized algorithms.
(4) The neonatologist assessed and classiﬁed factors contribut-
ing to MAE rates by reviewing all errors from the 2012 data
set.Table 3
Medication Administration Errors 2011 and 2012.
Medication MAEs Administrations
2011 2012 Overall totals 2011 2012 Overall
Narcotic medications
Fentanyl 2 2 4 593 412 1005
Morphine 5 6 11 1971 2038 4009
Vasoactive medications
Dobutamine 0 0 0 8 2 10
Dopamine 3 2 5 32 11 43
Epinephrine 184 105 289 1647 1243 2890
Milrinone 4 1 5 1216 709 1925
Vasopressin 11 43 54 128 293 421
Fluids
IVF 137 136 273 4270 4297 8567
PN 302 347 649 8613 11,601 20,124
Lipid 103 100 203 6319 8908 15,227
Insulin
Insulin 9 4 13 284 172 456
IVF – intravenous ﬂuids; PN – parenteral nutrition.3. Results
3.1. Error rates for automated MAE detection algorithms
3.1.1. Narcotic medications
The combined average administration error rates in 2011 and
2012 identiﬁed by the algorithms were 0.4% (4/1005) for fentanyl
and 0.3% (11/4009) for morphine. As shown in Table 3, the overall
rates of MAEs were similar in 2011 and 2012 for both medications,
with respective error rates for fentanyl of 0.3% (2/593) and 0.5%
(2/412) and for morphine of 0.3% (5/1971) and 0.3% (6/2038). In
comparison, incident reporting identiﬁed four MAEs in fentanyl
administrations and six errors in morphine administrations. The
majority of MAEs identiﬁed by the algorithms for both fentanyl
and morphine were administration of doses that were too high
or too low compared to ordered doses, while incident reporting
most frequently identiﬁed pump programming errors that resulted
in the wrong dose being administered. There were unique errors
identiﬁed by each method, with only two errors identiﬁed by both
the algorithm and incident reporting.
3.1.2. Vasoactive medications
Evaluating combined average MAE rates in 2011 and 2012, the
algorithms detected no errors in dobutamine administrations
(0/10), a low error rate of 0.3% in milrinone administrations
(5/1925), and higher error rates for dopamine (5/43 = 11.6%), epi-
nephrine (289/2890 = 10.0%), and vasopressin administrations
(54/421 = 12.8%), as shown in Table 3. Of interest, the algorithm
identiﬁed one epinephrine administration error that resulted in a
ten-fold dosing error. In comparison, incident reporting identiﬁed
seven epinephrine administration errors, two milrinone errors,
and one vasopressin error (Table 3). The vast majority of errors
identiﬁed by the algorithms were due to titration of the medication
dose without a written order, while incident reporting identiﬁed
administration of erroneous high doses and the presence of
clamped lines during drug administration as the most common
errors.
3.1.3. IVF, PN and lipids
Similar combined average MAE rates in 2011 and 2012 identi-
ﬁed by the algorithms are 3.2% (273/8567) for IVF, 3.2%
(649/20124) for PN, and 1.3% (203/15227) for lipid administrationsMAE rate MAEs identiﬁed by
incident reporting
totals 2011 (%) 2012 (%) Overall totals (%)
0.3 0.5 0.4 4
0.3 0.3 0.3 6
0 0 0 0
9.4 18.2 11.6 0
11.2 8.4 10 7
0.33 0.14 0.3 2
8.6 14.7 12.8 1
3.2 3.2 3.2 13
3.5 3.0 3.2 13
1.6 1.1 1.3 11
3.2 2.3 2.9 3
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were again low in comparison, with 13 IVF errors, 13 PN errors,
and 11 lipid errors noted (Table 3). The most common error iden-
tiﬁed by the algorithms for all three parenteral ﬂuids was delivery
of a medication rate that was lower than ordered, with higher rates
than ordered being the second most common error. Incident
reports usually reﬂected administration of higher rates than
ordered, and incident reporting often identiﬁed a second ﬂuid
administered incorrectly.
As part of our analysis, we assessed the ability of the algorithm to
identify ﬂuid rates and changes in enteral feeding order comments
and nurse communication orders using NLP-based regular expres-
sion. Sensitivity rates for algorithm detection of rates ranged from
83% to 100% and PPV was 100% for all algorithms. (Appendix C).
3.1.4. Insulin
The combined average MAE rate for continuous insulin drip
administrations identiﬁed by the algorithms on the 2011 and
2012 data set was 2.9% (13/456) with one ten-fold dosing error
identiﬁed. The overall rates of MAEs were similar in 2011 and
2012 with error rates of 3.2% and 2.3% respectively.
Comparatively, only three insulin errors were reported in incident
reporting. The most common issue identiﬁed by the algorithms
was the late entry of verbal orders, with the median time being
82 min and the maximum time being 190 min, followed by the
administration of doses that were higher than ordered. Incident
reporting also reﬂected doses that were higher than ordered and
one delayed administration.
As part of our analysis, we used the algorithm to assess adher-
ence to the clinical guideline for insulin administration in 25
patients who received continuous insulin infusions in 2011. The
algorithm identiﬁed that 48% (12/25) of insulin initiations accu-
rately followed the guideline, but 52% (13/25) of insulin initiations
did not follow the guideline, with equal deﬁciencies in failing to
decrease the glucose infusion rate to <5 mg/kg/min (24%; 6/25)
and failure to initiate the correct dose (24%; 6/25). One patient
did not have two consecutive glucose values >180 mg/dL (4%;
1/25) before initiating insulin therapy. For discontinuation of insu-
lin, the algorithm found that 68% (17/25) of insulin infusions fol-
lowed the guideline, while seven infusions continued when the
blood glucose level was <200 mg/dL and was decreasing
>50 mg/dL/h (28%; 7/25). One infusion was continued with a glu-
cose level <100 mg/dL (4%; 1/25).
3.2. Algorithm performance evaluation on PPV, sensitivity, and
speciﬁcity
As described in the study methods, algorithm performance
compared to manual review is shown in Table 4. Overall, 259
administration errors were identiﬁed upon manual review, 235
of which were detected by the automated algorithms while inci-
dent reporting only identiﬁed seven errors. Although incident
reporting has a slightly higher speciﬁcity (100% vs. 98.2%), the
automated algorithms have a much higher sensitivity (82.1% vs.
5.5%) and PPV (70.2% vs. 50.0%). False positive results occurred
when the algorithms failed to recognize weaning orders in the
free-text comments, when medications being administered at the
time of admission were documented prior to orders being entered,
and when multiple order audits occurred together. False negative
results occurred when the algorithm accepted the original order
despite intervening order audits or missed free-text comments.
3.3. Trigger tool comparison
Results from the CHA trigger tool assessment, obtained over the
same 2011–2012 time period, revealed ﬁve medication errors in 33neonatal patients, none of which were from the medication cate-
gories evaluated by the algorithms. The ﬁve adverse drug events
detected using the trigger tool were related to vancomycin, pred-
nisolone, sirolimus and anesthetic agent use. In addition, our previ-
ous work demonstrated that the algorithms identiﬁed consistent
error rates with those found using trigger tools when identical trig-
gers were evaluated, but errors were identiﬁed in a more resource
efﬁcient manner [40].3.4. Overall MAE rates
Our data accounted for the majority of continuous medications
administered in the NICU, although we did not have information
on continuous midazolam, or rarely used continuous medications
like epoprostenol, nitroprusside, or prostaglandin. Overall rates of
administration errors identiﬁed by the algorithms for the evalu-
ated continuous medications were 46 errors per 1000 patient days
and 103 errors per 100 NICU admissions in 2011 and 45 errors per
1000 patient days and 102 errors per 100 NICU admissions in 2012.
In summary, there were 1506 errors for 54,677 evaluated medica-
tion administration records (eMARs), for an administration error
rate of 2.8%.4. Discussion
The performance achieved by our automated algorithms for
medication error detection was higher than that achieved through
incident reporting and trigger tool methodology. Using incident
reports and chart review, Kaushal found 91 medication errors per
100 NICU admissions [14]. Using incident reporting and direct
observation of a select sample of continuous medication infusions,
Larsen observed 3.5 errors per 1000 medication infusions [20].
Historically, measuring rates of medication errors in the NICU
using incident reporting, chart review, or direct observation has
been difﬁcult and resource intensive. Our data directly compares
the rates of errors identiﬁed electronically to those identiﬁed by
incident reporting, and supports other studies that have found sig-
niﬁcant underreporting of errors based on incident reporting [9].
Our data also captures a much broader sample than that evaluated
by trigger tool methodology. One of the signiﬁcant strengths of our
study is the ability to analyze all medication administration
records for a given medication automatically, rather than a small
sample, as well as the ability to analyze multiple years of data in
a time and resource-efﬁcient manner. Importantly, the algorithms
identiﬁed rare but critical ten-fold dosing errors of high-risk med-
ications that would beneﬁt from early recognition. In an era when
most institutions are adopting EHRs, the use of computerized algo-
rithms holds the potential for widespread error identiﬁcation.
Although the algorithms have currently been tested only in a single
EHR system, ongoing work includes assessment of generalizability
to other institutions and other EHR products. Further, the potential
to implement the algorithms as a real-time error monitor holds
promise as a means to mitigate ongoing errors in continuous ﬂuid
and medication administrations. Our future work involves testing
of the algorithms prospectively and in real-time to mitigate error
and to prevent harm.
Improved MAE identiﬁcation using the algorithms allowed us to
observe factors that contributed to higher error rates, including
bedside weaning, use of verbal orders, non-standardization of writ-
ten weaning orders for both vasopressors and PN/ﬂuids, and errors
associated with syringe changes. For example, medications such as
dopamine, epinephrine, or vasopressin, which are often weaned at
the bedside based on ordered blood pressure parameters, had sig-
niﬁcantly higher error rates than medications started at a single
dose and discontinued without weaning. Verbal orders were also
Table 4
Error detection performance of the automated algorithm and incident reporting compared to manual review of administrations
for each medication in the 2012 data subset.
Manual review Algorithms Incident reporting
Narcotic medications
Fentanyl No. Detected 2 2 0
Sensitivity [CI] 100.0% [19.3–100] 0 [0–80.7]
Speciﬁcity [CI] 100.0% [99.6–100] 100% [99.1–100]
PPV [CI] 100.0% [12.3–100]
Morphine No. Detected 3 4 1
Sensitivity [CI] 100% [30.5–100.0] 33.3% [1.2–33.9]
Speciﬁcity [CI] 99.9% [99.44–99.9] 100% [99.8–100]
PPV [ CI] 75% [20.3.7–95.8] 100% [16.6–100]
Vasoactive medications
Dobutamine No. Detected 0 0 0
Sensitivity [CI]
Speciﬁcity [CI] 100% [19.3–100] 100% [19.3–100]
PPV [CI]
Dopamine No. Detected 2 2 0
Sensitivity [CI] 100% [19.3–100] 0% [0–80.7]
Speciﬁcity [CI] 88.9% [51.7–98.2] 100% [66.2–100]
PPV [CI] 66.7% [11.6–94.5]
Epinephrine No. Detected 116 107 0
sensitivity [CI] 92.2% [85.8–96.4] 0% [0–3.2]
Speciﬁcity [CI] 96.2% [94.9–97.2] 100% [99.7–100]
PPV [CI] 71.3% [63.4–78.4]
Milrinone No. Detected 1 1 0
Sensitivity [CI] 100% [16.6–100] 0% [0–83.5]
Speciﬁcity [CI] 99.6% [98.8–99.9] 100% [99.5–100]
PPV [CI] 25% [4.1–79.7]
Vasopressin No. Detected 48 48 0
Sensitivity [CI] 100% [92.5–100] 0% [0–7.5]
Speciﬁcity [CI] 98.4% [95.8–99.5] 100% [98.1–100]
PPV [CI] 92.3% [81.4–97.8]
Fluids
IVF No. Detected 27 26 1
Sensitivity [CI] 96.3% [81–99.4] 3.7% [0.62–100]
Speciﬁcity [CI] 99.5% [98.8–99.8] 100% [99.6–100]
PPV [CI] 83.9% [66.3–94.5] 100% [16.6–100]
PN No. Detected 28 24 2
Sensitivity [CI] 85.7% [67.3–95.9] 7.1% [1.1–23.5]
Speciﬁcity [CI] 99.6% [99–99.9] 100% [99.6–100]
PPV [CI] 85.7% [67.3–95.9] 100% [19.3–100]
Lipids No. Detected 17 14 2
Sensitivity [CI] 82.3% [56.5–96] 11.8% [1.8–36.5]
Speciﬁcity [CI] 99.8% [99.3–99.9] 100% [99.6–100]
PPV [CI] 87.5% [61.6–98.1] 100% [19.3–100]
Insulin
Insulin No. Detected 4 4 1
Sensitivity [CI] 100% [40.2–100] 25% [4.1–79.7]
Speciﬁcity [CI] 100% [97.9–100] 100% [97.8–100]
PPV [CI] 100% [40.2–100] 100% [16.6–100]
Overall
Overall No. Detected 259 234 7
Sensitivity 82.1% 5.5%
Speciﬁcity 98.2% 100%
PPV 70.2% 50%
No. Detected: Number of detected errors; CI: conﬁdence interval; PPV: Positive Predictive Value.
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situations, and we found several cases where written orders were
placed hours after medication changes were initiated. We also
found frequent administration errors when a new medication syr-
inge was hung, as medications that had been weaned according to
weaning parameters were temporarily returned to the previously
ordered dose. As a unique error, we found that PN and lipids, often
administered together, were frequently interchanged, resulting in
an error for both medications. On the other hand, there are other
factors, such as human factors, that may have inﬂuenced error
rates that we may not have been able to observe. For example, pro-
viders may give less attention to familiar medications and more
attention to less familiar medications.The primary limitation to our study is that MAE identiﬁcation is
dependent on documentation in the EHR. There are situations
where medication administrations are not recorded in the EHR,
including during surgery and resuscitations. We did not review
anesthesia records or resuscitation paperwork and may have
missed medication errors during these periods. Second, the study
did not assess the level of harm associated with errors. Although
some of the medication administration errors detected by the algo-
rithms may not be harm causing, our goal was to create a tool that
detected dosing discrepancies of 0.1 or greater between medica-
tion order and medication administration doses. Our thinking
was that to effectively avoid errors that can cause patient harm,
improvements must be made on the underlying, more common
132 Q. Li et al. / Journal of Biomedical Informatics 57 (2015) 124–133and less-harmful system problems that lead to near misses, as
demonstrated in non-medical industries [41]. The algorithm
parameters can be customized, however, to allow for a greater tol-
erance of minor errors. Third, some identiﬁed errors may be a
result of erroneous documentation at the time of computer entry
rather than errors in drug administration. Fourth, some medication
administration dose errors may not be found in the EHR, such as
those resulting from errors in medication pump programming
[42]. We found that the algorithms did not identify several narcotic
errors identiﬁed by incident reporting involving pump program-
ming, especially programming of the wrong patient weight or
wrong medication concentration. Identiﬁcation of pump errors will
require novel methods with evaluation of manually downloaded or
wirelessly transmitted pump information for accurate identiﬁca-
tion. Fifth, we did not assess for all types of administration errors
and did not attempt to identify delays in administrations or incor-
rect routes of administration. We also did not assess for the pres-
ence of all order speciﬁcs, such as blood pressure correlation for
vasoactive medication weaning or the attainment of speciﬁc feed-
ing volumes prior to PN weaning. Sixth, due to the use of
non-standardized orders and the use of free-text comments for
specifying rate changes of ﬂuid and PN, the extraction of unstruc-
tured data was more difﬁcult, and some errors may have been
missed based on the lower sensitivity for detection. Most of these
limitations would result in higher rates of MAE than we have
reported. Finally, some discrepancies between ordered and admin-
istered medications may be due to errors in ordering; our method-
ology assumed that the order was correct and we did not attempt
to look for incorrect dosing orders.5. Conclusions
MAEs are common, but error reporting mechanisms such as
incident reporting are insufﬁcient to identify errors comprehen-
sively. The EHR is a rich but underutilized source for MAE detec-
tion. Overall, our study demonstrates that automated detection
of MAEs through the EHR is feasible and performs better, with
higher sensitivity and precision, than currently used error detec-
tion systems such as incident reporting. Improved error identiﬁca-
tion allowed us to observe factors in the processes of medication
ordering and administration that contribute to errors and are likely
to be rectiﬁed through improvement work. Accurate error identiﬁ-
cation in continuously administered medications makes interven-
tion possible, and future work will focus on real-time detection
of ameliorable medication errors with physician and nurse notiﬁ-
cation. By systematically detecting and intercepting these errors,
we will shift neonatal patient safety from passive reporting of
errors to proactive identiﬁcation and mitigation of unsafe care.Conﬂict of interest
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